Idaho Attorney General Lawrence Wasden has announced a settlement with pharmaceutical giant GlaxoSmithKline, LLC (GSK) and SB Pharmco Puerto Rico, Inc. (SB Pharmco) that will give the state a little over $600,000. The settlement includes resolution of claims made by Idaho and 37 other states against the drug companies.
Information in this post gathered in association with an Oakland personal injury lawyer
The announcement of the settlement was reported in The Spokesman-Review in “Idaho gets $600K in pharmaceutical settlement.” The action against the two companies included allegations of unfair and deceptive practices in the manufacture and distribution of Paxil CR, an antidepressant; Kytril, an anti-nausea medication used by chemotherapy and radiation patients; Bactroban, a topical antibiotic used for skin infections; and Avandamet, a type 2 diabetes medicine.
The drugs were being manufactured in a plant in Cidra, Puerto Rico. Attorney General Wasden had claimed that substandard manufacturing processes had contaminated or adulterated the drugs. The plant was closed in 2009.
GSK and SB Pharmco are also enjoined from making false and deceptive claims regarding any drugs that were manufactured at its Cidra plant.
The drugs in question have either been recalled or have expired. No details were released as to whether anyone was harmed by the defective drugs. Any terms involving the other 37 states were not disclosed.
The settlement still must be approved by the Fourth District Court in Ada, Idaho.